Psykoterapeutisk og psykofarmakologisk behandling af PTSD

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Standard

Psykoterapeutisk og psykofarmakologisk behandling af PTSD. / Lohmann, Jessica Mariana Carlsson; Sandahl, Hinuga.

I: Ugeskrift for Læger, Bind 184, V11210872, 2022.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Harvard

Lohmann, JMC & Sandahl, H 2022, 'Psykoterapeutisk og psykofarmakologisk behandling af PTSD', Ugeskrift for Læger, bind 184, V11210872. <https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v11210872_web.pdf>

APA

Lohmann, J. M. C., & Sandahl, H. (2022). Psykoterapeutisk og psykofarmakologisk behandling af PTSD. Ugeskrift for Læger, 184, [V11210872]. https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v11210872_web.pdf

Vancouver

Lohmann JMC, Sandahl H. Psykoterapeutisk og psykofarmakologisk behandling af PTSD. Ugeskrift for Læger. 2022;184. V11210872.

Author

Lohmann, Jessica Mariana Carlsson ; Sandahl, Hinuga. / Psykoterapeutisk og psykofarmakologisk behandling af PTSD. I: Ugeskrift for Læger. 2022 ; Bind 184.

Bibtex

@article{e985d301dbac4d648b1e77f8ac006db8,
title = "Psykoterapeutisk og psykofarmakologisk behandling af PTSD",
abstract = "According to WHO, PTSD is one of the diagnoses causing the highest number of “days out of role”/year. Current recommendations for evidence-based treatment of PTSD are largely the same across international guidelines. Common to these is that psychotherapeutic treatment is first-choice and psychopharmacological treatment issecond choice. First-choice psychotherapeutic treatment is trauma-focused cognitive behavioural therapy, whileSSRIs are first-choice psychopharmacological treatment. However, there is still a need for further research intotreatments as well as optimising access to existing treatment options.",
author = "Lohmann, {Jessica Mariana Carlsson} and Hinuga Sandahl",
year = "2022",
language = "Dansk",
volume = "184",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",

}

RIS

TY - JOUR

T1 - Psykoterapeutisk og psykofarmakologisk behandling af PTSD

AU - Lohmann, Jessica Mariana Carlsson

AU - Sandahl, Hinuga

PY - 2022

Y1 - 2022

N2 - According to WHO, PTSD is one of the diagnoses causing the highest number of “days out of role”/year. Current recommendations for evidence-based treatment of PTSD are largely the same across international guidelines. Common to these is that psychotherapeutic treatment is first-choice and psychopharmacological treatment issecond choice. First-choice psychotherapeutic treatment is trauma-focused cognitive behavioural therapy, whileSSRIs are first-choice psychopharmacological treatment. However, there is still a need for further research intotreatments as well as optimising access to existing treatment options.

AB - According to WHO, PTSD is one of the diagnoses causing the highest number of “days out of role”/year. Current recommendations for evidence-based treatment of PTSD are largely the same across international guidelines. Common to these is that psychotherapeutic treatment is first-choice and psychopharmacological treatment issecond choice. First-choice psychotherapeutic treatment is trauma-focused cognitive behavioural therapy, whileSSRIs are first-choice psychopharmacological treatment. However, there is still a need for further research intotreatments as well as optimising access to existing treatment options.

M3 - Tidsskriftartikel

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V11210872

ER -

ID: 344374836